The impact of ethnicity on the natural history of autoimmune hepatitis
Open Access
- 1 December 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 46 (6) , 1828-1835
- https://doi.org/10.1002/hep.21884
Abstract
The impact of ethnicity on the natural history of autoimmune hepatitis (AIH) has not been well characterized. The aim of this study was to assess the natural history of AIH in blacks in comparison with others (nonblacks). This was a 10-year (June 1996 to June 2006) retrospective analysis of patients with AIH from a single tertiary care center. The diagnosis of AIH was defined by the criteria established by the International Autoimmune Hepatitis Club. A poor outcome was defined as liver failure at presentation, failure to achieve remission, need for liver transplantation, and/or death. One hundred one patients with AIH were eligible for the study. Black patients were more likely to have cirrhosis (56.7% versus 37.5%, P = 0.061), have liver failure at the initial presentation (37.8% versus 9.3%, P = 0.001), and be referred for liver transplantation (51.3% versus 23.4%, P = 0.004). The overall mortality was also significantly higher in black patients (24.3% versus 6.2%, P = 0.009). Compared with nonblacks, blacks had more advanced hepatic fibrosis (3.6 ± 2.7 versus 2.1 ± 2.4, P = 0.013). A Kaplan-Meier analysis showed that the probability of developing a poor outcome was significantly higher in blacks ( P = 0.003). Independent predictors of poor outcome were black ethnicity, the presence of cirrhosis, and the fibrosis stage at presentation. Black males were the group most likely to have a poor outcome (85.7%). Conclusion: Blacks, especially black men with AIH, have more aggressive disease at the initial presentation, are less likely to respond to conventional immunosuppression, and have a worse outcome than nonblacks. (Hepatology 2007.)Keywords
This publication has 31 references indexed in Scilit:
- Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitisAlimentary Pharmacology & Therapeutics, 2006
- Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitisJournal of Hepatology, 2005
- Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *Hepatology, 2005
- Factors Predicting Relapse and Poor Outcome in Type I Autoimmune Hepatitis: Role of Cirrhosis Development, Patterns of Transaminases During Remission and Plasma Cell Activity in the Liver BiopsyAmerican Journal of Gastroenterology, 2004
- Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitisLiver International, 2003
- Diagnosis and treatment of autoimmune hepatitisHepatology, 2002
- Drug Therapy in the Management of Type 1 Autoimmune HepatitisDrugs, 1999
- Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitisGastroenterology, 1997
- Prognosis of histological cirrhosis in type 1 autoimmune hepatitisGastroenterology, 1996
- Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factorsHepatology, 1991